Re: Prostate cancer progression and survival in BRCA2 mutation carriers.
Boormans
Joost L
JL
Department of Urology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Schröder
Fritz H
FH